approxim
practition
train
famili
medicin
travel
tropic
medicin
train
increasingli
embrac
emerg
medicin
last
year
escal
number
immigr
refuge
travel
present
emerg
depart
care
present
guidelin
regard
certif
qualif
requir
practic
travel
medicin
exist
glasgow
diploma
travel
medicin
first
diplom
cours
dtm
h
offer
communic
diseas
unit
univers
glasgow
sever
recogn
cours
current
offer
worldwid
sinc
istm
offer
voluntari
certif
knowledg
examin
requir
train
andor
practic
prerequisit
royal
colleg
physician
surgeon
glasgow
introduc
formal
examin
assess
knowledg
train
experienc
practition
licensur
provid
yellow
fever
vaccin
larg
regul
nation
region
health
care
author
europ
unit
state
cdc
publish
health
inform
intern
travel
yellow
book
serv
refer
includ
updat
malaria
prophylaxi
treatment
guidelin
advis
intern
travel
health
risk
http
wwwnccdcgovtravel
similar
guidelin
avail
sever
nation
health
servic
specialti
societi
public
health
agenc
canada
travel
health
guidelin
http
wwwphacaspcgccatmppmv
health
protect
scotland
travax
web
site
http
wwwtravaxnhsuk
rigor
structur
continu
medic
educ
includ
outpati
clinic
hospit
round
didact
lectur
laboratori
work
provid
mani
tropic
countri
worldwid
specialti
organ
tropic
medicin
consult
multipl
studi
underlin
import
appropri
train
experi
ongo
educ
provid
individu
proper
peritravel
care
gener
travel
medicin
practic
involv
educ
care
travel
trip
moreprolong
stay
anoth
countri
maintain
travel
wellb
safeti
avoid
import
infecti
agent
note
diseas
surveil
care
migrant
refuge
becom
increasingli
import
addit
practic
pretravel
consult
begin
evalu
health
immun
statu
travel
conclud
assess
plan
base
itinerarybas
risk
grow
number
decisionsupport
resourc
tool
avail
facilit
process
includ
govern
travel
advic
site
travax
tropim
gideon
prevent
individu
diseas
address
combin
patient
educ
vaccin
provis
chemoprophylaxi
use
method
avoid
insect
exposur
food
water
precaut
provis
medic
selftreat
certain
ill
provis
travel
evacu
insur
desir
individu
recommend
base
epidemiolog
determin
likelihood
injuri
diseas
occurr
individu
area
individu
travel
health
experi
health
belief
model
toler
risk
time
pretravel
consult
may
provid
cogent
argument
travel
postpon
pregnant
women
plan
travel
malari
area
routin
medic
dental
care
updat
trip
patient
advis
carri
suffici
suppli
requir
medic
drug
purchas
oversea
may
drug
may
manufactur
similar
standard
avail
develop
countri
may
contain
counterfeit
medic
contamin
detail
plan
equip
medic
larg
special
group
expedit
beyond
scope
articl
readili
avail
sever
articl
text
onlin
inform
site
provid
istm
wilder
medicin
societi
ideal
initi
pretravel
consult
occur
least
week
patient
departur
allow
adequ
time
serial
immun
immun
take
effect
begin
antimalari
must
start
arriv
endem
area
assess
potenti
advers
reaction
vaccin
medic
travel
less
time
travel
remain
import
see
provid
necessari
vaccin
antimalari
medic
counsel
medic
may
caus
vaccin
interact
interfer
vaccinederiv
immun
protect
exampl
interv
least
day
schedul
dose
oral
cholera
vaccin
initi
dose
chloroquin
mefloquin
gener
attenu
live
viru
vaccin
bacteri
vaccin
contraind
person
alter
immun
compet
pregnanc
multipl
vaccin
may
given
differ
site
visit
limit
travel
anticip
toler
multipl
inject
minor
side
effect
live
viru
vaccin
may
given
day
without
interf
immun
efficaci
otherwis
live
viru
vaccin
dose
separ
least
month
immun
hepat
may
provid
acceler
schedul
individu
medic
histori
current
medic
allergi
immun
review
influenc
vaccin
indic
potenti
contraind
exampl
individu
egg
allergi
potenti
contraind
vaccin
measl
mump
rubella
yellow
fever
influenza
rabi
pretravel
histori
includ
explor
document
individu
purpos
travel
specif
travel
itinerari
durat
includ
discuss
plan
possibl
stopov
side
trip
attent
season
localespecif
varianc
risk
infect
injuri
exampl
individu
travel
busi
rio
de
janeiro
might
wish
take
side
trip
amazon
requir
addit
counsel
vaccin
prophylaxi
type
accommod
like
style
eat
drink
trip
discuss
rel
risk
plan
activ
also
review
rel
risk
exampl
spelunk
white
water
raft
fresh
water
salt
water
swim
dive
trek
remot
area
potenti
domest
wild
anim
exposur
degre
interact
travel
local
popul
travel
engag
agricultur
wildlif
biolog
construct
local
medic
humanitarian
work
individu
travel
area
unrest
conflict
current
outbreak
diseas
area
violenc
conflict
describ
state
depart
world
health
organ
cdc
pan
american
health
organ
prome
site
also
play
import
role
pretravel
counsel
immun
common
reason
patient
seek
pretravel
consult
travel
tropic
develop
countri
western
europ
north
america
expos
communic
diseas
infrequ
seen
home
countri
gener
high
sanit
standard
mandatori
childhood
immun
appropri
immun
shown
increas
likelihood
travel
remain
healthi
cdc
current
divid
travel
immun
categori
routin
recommend
requir
firsttim
travel
may
dismay
shepherd
shoff
number
vaccin
recommend
rout
administr
cost
mani
vaccin
cover
regular
health
insur
vaccin
rel
risk
travelrel
ill
priorit
travel
travel
may
elect
obtain
routin
vaccin
primari
care
provid
maxim
insur
coverag
immun
administ
travel
record
copi
yellow
booklet
intern
certif
vaccin
recogn
kept
individu
passport
specif
page
valid
yellow
fever
vaccin
routin
immun
tetanu
diphtheria
pertussi
measl
mump
rubella
varicella
pneumococcu
influenza
review
updat
warrant
travel
counsel
potenti
differ
influenza
risk
likelihood
vaccin
efficaci
travel
semitrop
tropic
area
temper
area
northern
southern
hemispher
infrequ
continu
presenc
wild
polioviru
clinic
polio
develop
countri
cdc
current
recommend
adult
travel
receiv
primari
polio
vaccin
seri
either
inactiv
polioviru
vaccin
ipv
oral
polio
vaccin
opv
receiv
singl
lifetim
addit
dose
ipv
cdc
current
recommend
adult
younger
year
receiv
dose
tdap
tetanusdiptheriapertussi
vaccin
one
recommend
booster
particularli
relev
travel
increas
likelihood
exposur
diphtheria
pertussi
develop
countri
individu
born
gener
consid
immun
measl
mump
individu
born
document
dose
measlesmumpsrubella
mmr
vaccin
unless
medic
contraind
laboratori
evid
immun
diseas
document
providerdiagnos
measl
mump
individu
receiv
inactiv
kill
measl
vaccin
measl
vaccin
unknown
type
period
revaccin
dose
measl
vaccin
signific
risk
measl
exposur
second
mmr
vaccin
administ
minimum
day
first
recommend
adult
work
outbreak
set
health
care
set
develop
countri
plan
travel
intern
recommend
vaccin
includ
help
protect
travel
contract
ill
present
part
world
prevent
import
infecti
diseas
across
intern
border
vaccin
individu
need
depend
sever
factor
includ
travel
age
health
statu
previou
immun
destin
season
year
individu
travel
length
time
individu
spend
specif
area
whether
travel
spend
time
rural
area
activ
individu
engag
whether
destin
current
experienc
diseas
outbreak
exampl
rabi
preexposur
prophylaxi
recommend
travel
spend
signific
time
outdoor
especi
rural
area
anticip
activ
spelunk
cycl
camp
hike
rabi
vaccin
also
recommend
travel
signific
occup
risk
veterinarian
longterm
travel
expatri
live
area
signific
exposur
risk
travel
involv
activ
might
bring
direct
contact
bat
carnivor
mammal
children
consid
higher
risk
rabi
exposur
tend
interact
anim
may
receiv
bite
may
report
bite
exposur
see
tabl
list
recommend
vaccin
travel
certain
countri
continu
next
page
continu
next
page
yellow
fever
vaccin
current
requir
intern
health
regul
travel
certain
countri
tropic
south
america
subsaharan
africa
updat
list
yellow
fever
vaccin
certif
requir
countri
author
us
yellow
fever
vaccin
clinic
found
cdc
travel
health
web
site
wwwcdcgovtravelcontentvaccinationsaspx
last
sever
year
quadrival
meningococc
vaccin
must
issu
year
less
day
arriv
requir
saudi
arabian
govern
infant
children
adult
pilgrim
annual
travel
hajj
immun
statu
check
issuanc
visa
issu
unless
document
complianc
provid
travel
health
provid
letter
may
issu
individu
unabl
receiv
vaccin
howev
guarante
issuanc
visa
hajj
travel
malaria
human
caus
speci
protozoan
genu
plasmodium
p
falciparum
p
vivax
p
oval
recent
split
subspeci
p
malaria
recent
much
less
frequent
p
knowlesi
malaria
primarili
transmit
bite
infect
femal
anophel
mosquito
although
transmiss
also
document
via
blood
transfus
organ
transplant
needl
share
anophel
spp
even
feeder
therefor
transmiss
occur
primarili
dusk
dawn
annual
malaria
caus
million
infect
million
death
global
larg
affect
children
area
central
south
america
part
caribbean
eastern
europ
asia
africa
oceania
see
fig
map
atrisk
area
malaria
transmiss
regularli
updat
map
avail
cdc
websit
wwwcdcgovmalariamapindexhtml
thirti
thousand
travel
europ
north
america
contract
malaria
year
case
report
us
resid
cdc
report
case
unit
state
acquir
subsaharan
africa
asia
caribbean
central
south
america
oceania
howev
consid
context
volum
travel
locat
region
highest
estim
rel
risk
west
africa
oceania
part
africa
south
asia
south
america
felt
moder
risk
wherea
portion
central
america
part
asia
rel
lower
risk
individu
travel
risk
vari
substanti
region
includ
area
differ
altitud
urban
versu
rural
travel
season
travel
level
risk
present
particular
itinerari
decid
whether
may
appropri
recommend
mosquito
avoid
method
mosquito
avoid
method
chemoprophylaxi
specif
intervent
even
short
exposur
experienc
cruis
ship
passeng
may
pose
risk
area
intens
transmiss
malaria
chemoprophylaxi
dynam
topic
risk
transmiss
influenc
individu
travel
behavior
may
uniformli
distribut
individu
countri
affect
chang
resist
pattern
avail
use
newer
older
drug
highestrisk
travel
firstor
secondgener
immigr
current
live
nonendem
countri
return
countri
origin
vfr
individu
often
consid
risk
grew
endem
area
believ
immun
unfortun
acquir
immun
lost
quickli
leav
endem
area
sever
option
malaria
chemoprophylaxi
current
avail
singl
regimen
ideal
travel
thorough
discuss
vector
avoid
malaria
chemoprophylaxi
treatment
may
found
elsewher
malaria
vaccin
develop
face
numer
challeng
sinc
initi
clone
malaria
antigen
earli
present
sever
question
remain
regard
vaccin
mode
action
parasit
complex
incomplet
understood
infect
biolog
efficaci
dosag
schedul
potenti
durat
effect
resourc
research
fund
rel
scarc
goal
vaccin
develop
either
prevent
bloodstag
infect
complet
via
destruct
sporozoit
enter
liver
kill
infect
hepatocyt
preerythrocyt
vaccin
limit
parasit
growth
densiti
blood
compart
via
destruct
infect
erythrocyt
bloodstag
vaccin
goal
provid
durabl
immun
respons
similar
efficaci
induc
natur
infect
signific
antigen
divers
barrier
develop
immun
preerythrocyt
blood
stage
parasit
develop
although
immun
sever
lifethreaten
diseas
evid
acquir
earli
childhood
area
intens
malaria
transmiss
clearli
demonstr
clinic
immun
vaccin
trial
limit
lack
immunolog
correl
effect
vaccin
individu
ideal
vaccin
direct
sever
novel
antigen
perhap
tcell
target
express
sever
stage
parasit
develop
like
highli
conserv
sequenc
robustli
recogn
vaccineinduc
immun
respons
sever
stagespecif
vaccin
candid
current
trial
prevent
p
falciparum
infect
one
preerythrocyt
vaccin
target
p
falciparum
circumsporozoit
protein
glaxosmithklin
rt
current
phase
trial
african
center
result
expect
end
phase
trial
vaccin
administ
mozambican
infant
week
age
stagger
routin
vaccin
report
good
safeti
profil
vs
seriou
advers
event
control
group
remain
somewhat
efficaci
month
geometr
mean
titer
anticircumsporozoit
antibodi
declin
euml
month
remain
higher
control
group
vaccin
efficaci
confid
interv
p
immunogen
data
similar
previous
report
older
children
adult
relat
anticircumsporozoit
antibodi
titer
protect
demonstr
mozambican
children
age
year
success
affect
global
malaria
elimin
also
crucial
attack
major
malari
speci
affect
human
vaccin
progress
p
vivax
caus
signific
morbid
mortal
central
south
america
eastern
mediterranean
asia
estim
million
million
case
annual
nearli
advanc
dengu
current
preval
arthropodborn
viral
ill
human
caus
serotyp
dengu
viru
denv
dengu
member
flavivirida
famili
yellow
fever
japanes
enceph
denv
transmit
human
via
bite
peridomest
daybit
aed
mosquito
promin
aed
aegypti
infect
denv
caus
spectrum
clinic
ill
rang
usual
mild
acut
selflimit
febril
ill
dengu
fever
lifethreaten
hemorrhag
capillari
leak
syndrom
dengu
hemorrhag
feverdengu
shock
syndrom
dhfdss
denv
caus
estim
million
million
case
dengu
fever
case
dhf
yearli
worldwid
billion
peopl
estim
risk
infect
fig
world
map
indic
region
known
risk
dengu
avail
http
wwwcdcgovncidoddvbid
dengu
unit
state
wit
return
autochthon
transmiss
sinc
initi
describ
texa
report
hawaii
florida
puerto
rico
geosentinel
data
collect
contin
show
dengu
fever
second
common
caus
system
febril
ill
exclud
diarrheal
diseas
return
travel
common
caus
travel
return
caribbean
south
america
southeast
asia
south
central
asia
brief
pathogenesi
dhfdss
reflect
complex
interact
viral
virul
determin
host
immun
system
infect
one
serotyp
denv
render
individu
immun
strain
life
transient
immun
strain
individu
risk
dhfdss
secondari
denv
infect
anoth
strain
increas
risk
dhfdss
also
occur
children
within
first
year
life
born
denvimmun
mother
observ
serv
basi
hypothesi
antibodydepend
immun
enhanc
ade
dhfdss
support
find
increas
peak
viremia
sever
dhfdss
ade
seen
vitro
denvinfect
monocyt
patholog
cytokin
respons
includ
increas
level
interferon
g
interleukin
tumor
necrosi
factor
g
cell
activ
thought
contribut
capillari
leak
syndrom
seen
dengu
hemorrhag
fever
dhf
hamper
absenc
valid
anim
model
dengu
infect
base
current
understand
virusimmun
system
interact
effect
vaccin
produc
high
titer
neutral
antibodi
strain
failur
achiev
potenti
increas
individu
risk
sever
dhfdss
challeng
natur
viru
infect
differ
strain
sever
tetraval
live
attenu
viru
candid
vaccin
develop
see
tabl
list
current
candid
denv
vaccin
tetraval
serolog
respons
observ
individu
trial
wherea
portion
tetraval
vaccin
shown
elicit
high
titer
respons
monoval
vaccin
shown
elicit
higher
level
neutral
antibodi
combin
multival
combin
mani
individu
mount
insuffici
level
neutral
antibodi
despit
multipl
immun
altern
vaccin
candid
includ
subunitbas
vaccin
contain
purifi
protein
dna
plasmid
shown
produc
protect
antibodi
mice
fairli
low
neutral
titer
live
attenu
vaccin
includ
dengu
dengueyellow
fever
chimera
nonrepl
vaccin
includ
viruslik
particl
dna
vaccin
inactiv
viru
vaccin
longlast
protect
neutral
antibodi
elicit
specif
serotyp
shown
poorli
crossreact
infect
anoth
serotyp
similar
problem
encount
develop
opv
imbal
seroconvers
overcom
administr
dose
multival
vaccin
tetraval
live
attenu
chimer
yellow
feverdengu
vaccin
enter
hase
trial
phase
trial
suggest
vaccin
safe
immunogen
preliminari
result
ongo
phase
efficaci
safeti
trial
thai
children
expect
avail
end
travel
diarrhea
signific
concern
among
intern
travel
usual
selflimit
consist
sever
day
wateri
diarrhea
sometim
accompani
lowgrad
fever
headach
malais
nausea
abdomin
cramp
thirti
seventi
percent
travel
may
affect
trip
larg
depend
travel
destin
postinfecti
sequela
includ
guillainbarr
reactiv
arthriti
mani
viral
bacteri
protozo
microorgan
caus
travel
diarrhea
symptom
may
result
ingest
preform
toxin
seen
bacillu
cereu
staphylococc
food
poison
botul
gener
bacteria
commonli
identifi
caus
acut
diarrheal
diseas
travel
visit
tropic
develop
countri
risk
modifi
geograph
region
time
year
presenc
local
outbreak
mani
case
caus
organ
may
identifi
enterotoxigen
strain
e
coli
etec
may
carri
heatlabil
heatstabl
plasmidcod
enterotoxin
commonli
identifi
bacteri
caus
oral
cholera
vaccin
produc
protect
travel
diarrhea
elicit
antibodi
product
b
subunit
cholera
toxin
crossreact
heatlabil
toxin
etec
past
decad
campylobact
speci
commonli
campylobact
jejuni
becom
increasingli
common
pathogen
agent
travel
diarrhea
seem
season
geograph
varianc
peak
incid
unit
state
summer
month
wherea
peak
incid
region
north
africa
occur
winter
month
bacteria
implic
travel
diarrhea
includ
enteroadher
e
coli
salmonella
spp
includ
typhi
shigella
spp
yersinia
enterocolitica
aeromona
vibrio
spp
includ
v
parahemolyticu
v
cholera
v
vulnificu
plesiomona
shigelloid
noroviru
common
caus
travel
diarrhea
case
notabl
sever
cruiseship
outbreak
rotaviru
astrovirus
less
common
pathogen
adult
hepat
e
also
caus
gastrointestin
ill
travel
hepat
e
particular
concern
immun
travel
medicin
pregnant
women
may
lead
sever
lifethreaten
ill
parasit
implic
travel
diarrhea
protozoa
includ
giardia
lamblia
less
commonli
cryptosporidium
spp
cyclospora
cayetenensi
isospora
belli
entamoeba
histolytica
occasion
dientamoeba
fragili
helminth
also
report
caus
diarrheal
diseas
travel
ingest
plant
fish
shellfish
toxinrel
ill
includ
acke
poison
scombroid
ciguatera
paralyt
neurotox
diarrheal
shellfish
poison
may
also
caus
gastrointestin
diseas
travel
pretravel
vaccin
counsel
regard
safe
food
water
practic
provid
vari
degre
protect
enter
infect
howev
even
greatest
care
risk
develop
diarrhea
remain
high
natur
protect
mechan
intestin
tract
promin
gastric
acid
immun
stimul
provid
vaccin
overwhelm
ingest
heavili
contamin
water
food
moder
travel
specif
immun
suppress
hypochlorhydria
gastrectomi
concurr
medic
environ
lack
appropri
sanitari
condit
clean
water
provid
signific
stool
contamin
highli
access
fli
attempt
select
safe
food
freshli
prepar
serv
hot
counteract
contamin
introduc
prepar
storag
handl
although
mani
travel
want
experi
local
cultur
cuisin
commonsens
food
water
precaut
may
help
individu
make
safer
choic
precaut
harder
maintain
vfr
stay
local
home
pursu
adventur
travel
stay
highli
contamin
area
prolong
period
time
articl
focu
detail
discuss
food
water
precaut
water
treatment
treatment
prevent
travel
diarrhea
present
vaccin
avail
prevent
common
caus
travel
diarrhea
hepat
vaccin
oral
intramuscular
typhoid
vaccin
effect
well
toler
although
limit
data
address
actual
level
protect
afford
oral
inject
typhoid
vaccin
travel
nonendem
area
visit
endem
area
cholera
vaccin
seem
moder
effect
strain
transcutan
e
coli
lt
vaccin
current
phase
trial
addit
pretravel
recommend
jet
lag
mitig
protect
sun
exposur
venou
thrombosi
avoid
prevent
treatment
altitud
ill
baric
risk
marin
bite
envenom
attend
dive
water
sport
risk
extrem
heat
cold
depend
individu
travel
agenda
safeti
regul
practic
less
preval
mani
nation
unit
state
canada
europ
us
medic
insur
polici
provid
coverag
ill
accid
occur
outsid
countri
coverag
medic
evacu
howev
mani
compani
provid
insur
thought
discuss
topic
manag
travel
return
ill
lie
outsid
scope
articl
summari
individu
travel
busi
pleasur
grown
tremend
past
sever
decad
increas
number
atrisk
individu
travel
travel
visit
remot
danger
area
travel
potenti
face
sever
risk
travel
thorough
epidemiolog
itinerarybas
discuss
manag
risk
travel
provid
appropri
educ
experienc
provid
care
take
consider
individu
risk
toler
medic
belief
system
financ
provid
individu
abil
shepherd
shoff
travel
safe
maxim
experi
trip
inform
glean
ill
injuri
experienc
travel
infect
develop
travel
potenti
brought
back
home
countri
continu
improv
care
inform
home
countri
potenti
risk
citizen
improv
global
manag
transmiss
ill
